The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework
This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
We should applaud the State of Washington for taking initiative in this important area, but we must acknowledge that the health record bank is just the flip side of the coin regarding the question of centralized or federated models for HIE. Beginning with the CHINs of the early 90's until now,...
United Therapeutics, a profitable US biotech company is about 12 months away from FDA approval of Inhaled Treprostinil for Pulmonary Arterial Hypertension. This drug will significantly add to the Company’s current 60% prostacyclin market share and help ensure the continued 30% revenue growth rate...
Pfizer attempts to leverage their original purchase by a sale of assets and retention of portions of the Esperion assets. They appear to be retaining a portion of the research of the company while divesting the remaining technology. They are keeping a small equity position in Esperion...
Microbes have a remarkable ability to mutate to allow for their survival. Biologics can introduce new means of treating invections, but are unlikely to overcome the ability of them to become resistant. Several biological components have been studied by companies and claim lack of resistance....
Have a daughter who is a retired school teacher. She was required to perform in life's real world as a student teacher for a period of roughly six months prior to her graduation. Points of requirement: 1. Opportunity to observe the teacher who was her mentor and evaluator. 2. ...
Stem cells have a great potential for a wide range of medical treatments. Laying out the direction to allow for clinical studies is an important step. Cancer Stem cell research is a new area where modulation of stem cell activity may prevent metastatic events. The FDA's concern for embryonic...
It often takes several attempts to finalize the Patent Claims and language to satify the examiner. The limitation of such attempt would place an undue burden on companies and would certainly result in loss of coverage of Intellectual Property (IP). Loss of IP results in reduction of a company...
Development of plaque in arteries takes place over a lifetime. There have been studies suggesting plaque removal can happen over shorter periods, but data demonstration that this solves medical problems is not available. Complicatons like heart attacks come from the unstable plaque...
Larger R&D is important to developing products which have large capital requirements and need for large groups. Smaller groups can act much faster when developing products with managable resouce needs. Smaller groups working independently from a large corporation have several...
Japan is the second largest generic market in the world. Kyowa Pharmaceuticals has a real presence in the Japanese pharmaceutical market. Allows Kyowa to leverage low cost Indian manufacturing while Lupin gains a large and growing market for distribution.